{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:03:37Z","timestamp":1763535817094},"reference-count":28,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-354","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T22:12:55Z","timestamp":1611958375000},"page":"186-192","source":"Crossref","is-referenced-by-count":4,"title":["Subclinical Cardiomyopathy in Miyoshi Myopathy Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging"],"prefix":"10.1536","volume":"62","author":[{"given":"Sarah Ming Li","family":"Tan","sequence":"first","affiliation":[{"name":"School of Medicine, University of New South Wales"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching Ching","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, National University Hospital"},{"name":"Yong Loo Lin School of Medicine, National University of Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong Bing","family":"Tan","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore"},{"name":"Department of Pathology, National University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Lin","family":"Chin","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore"},{"name":"Division of Paediatric Genetics & Metabolism, Department of Paediatrics, Khoo Teck Puat - National University Children's Medical Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash R","family":"Paliwal","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore"},{"name":"Division of Neurology, Department of Medicine, National University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay Wei Ping","family":"Ng","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore"},{"name":"Division of Neurology, Department of Medicine, National University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqin","family":"Lin","sequence":"additional","affiliation":[{"name":"Yong Loo Lin School of Medicine, National University of Singapore"},{"name":"Department of Cardiology, National University Heart Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Harris E, Bladen CL, Mayhew A, <i>et al<\/i>. The clinical outcome study for dysferlinopathy: An international multicenter study. Neurol Genet 2016; 2: e89.","DOI":"10.1212\/NXG.0000000000000089"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fanin M, Angelini C. Progress and challenges in diagnosis of dysferlinopathy. Muscle Nerve 2016; 54: 821-35.","DOI":"10.1002\/mus.25367"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Miyoshi K, Kawai H, Iwasa M, Kusaka K, Nishino H. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case. Brain 1986; 109: 31-54.","DOI":"10.1093\/brain\/109.1.31"},{"key":"4","unstructured":"4. Miyoshi K. Four cases of distal myopathy in two families. Jpn J Hum Genet 1967; 12."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Urtizberea JA, Bassez G, Leturcq F, <i>et al<\/i>. Dysferlinopathies. Neurol India 2008; 56: 3.","DOI":"10.4103\/0028-3886.43447"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Finsterer J, St\u00f6llberger C. Heart disease in disorders of muscle, neuromuscular transmission, and the nerves. Korean Circ J 2016; 46: 117-34.","DOI":"10.4070\/kcj.2016.46.2.117"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nguyen K, Bassez G, Krahn M, <i>et al<\/i>. Phenotypic study in 40 patients with dysferlin gene mutations: High frequency of atypical phenotypes. Arch Neurol 2007; 64: 1176-82.","DOI":"10.1001\/archneur.64.8.1176"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Klinge L, Aboumousa A, Eagle M, <i>et al<\/i>. New aspects on patients affected by dysferlin deficient muscular dystrophy. J Neurol Neurosurg Psychiatry 2010; 81: 9.","DOI":"10.1136\/jnnp.2009.178038"},{"key":"9","unstructured":"9. Kuru S, Yasuma F, Wakayama T, <i>et al<\/i>. A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy. Rinsho Shinkeigaku 2004; 44: 375-8."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wenzel K, Geier C, Qadri F, <i>et al<\/i>. Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) 2007; 85: 1203-14.","DOI":"10.1007\/s00109-007-0253-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Suzuki N, Takahashi T, Suzuki Y, <i>et al<\/i>. An autopsy case of a dysferlinopathy patient with cardiac involvement. Muscle Nerve 2012; 45: 298-9.","DOI":"10.1002\/mus.22247"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Choi ER, Park SJ, Choe YH, <i>et al<\/i>. Early detection of cardiac involvement in Miyoshi myopathy: 2D strain echocardiography and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12: 31.","DOI":"10.1186\/1532-429X-12-31"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rosales XQ, Moser SJ, Tran T, <i>et al<\/i>. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I. J Cardiovasc Magn Reson 2011; 13: 39.","DOI":"10.1186\/1532-429X-13-39"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nishikawa A, Mori-Yoshimura M, Segawa K, <i>et al<\/i>. Respiratory and cardiac function in Japanese patients with dysferlinopathy. Muscle Nerve 2016; 53: 394-401.","DOI":"10.1002\/mus.24741"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sindoni A, Rodolico C, Pappalardo MA, Portaro S, Benvenga S. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Rev Endocr Metab Disord 2016; 17: 499-519.","DOI":"10.1007\/s11154-016-9357-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Han R, Campbell KP. Dysferlin and muscle membrane repair. Curr Opin Cell Biol 2007; 19: 409-16.","DOI":"10.1016\/j.ceb.2007.07.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chase TH, Cox GA, Burzenski L, Foreman O, Shultz LD. Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B. Am J Pathol 2009; 175: 2299-308.","DOI":"10.2353\/ajpath.2009.080930"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Han R, Bansal D, Miyake K, <i>et al<\/i>. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 2007; 117: 1805-13.","DOI":"10.1172\/JCI30848"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Guglieri M, Magri F, D&apos;Angelo MG, <i>et al<\/i>. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat 2008; 29: 258-66.","DOI":"10.1002\/humu.20642"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Salerno M, Sharif B, Arheden H, <i>et al<\/i>. Recent advances in cardiovascular magnetic resonance: Techniques and applications. Circ Cardiovasc Imaging 2017; 10: 6.","DOI":"10.1161\/CIRCIMAGING.116.003951"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lamacie MM, Warman-Chardon J, Crean AM, Florian A, Wahbi K. The added value of cardiac magnetic resonance in muscular dystrophies. J Neuromuscul Dis 2019; 6: 389-99.","DOI":"10.3233\/JND-190415"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tiet M, Fernandez-Torr\u00f3n R, Bourke J, <i>et al<\/i>. Is cardiac dysfunction a feature of dysferlinopathy? Data from the clinical outcome study of Dysferlinopathy. Neuromuscul Disord 2018; 28: S5-6.","DOI":"10.1016\/S0960-8966(18)30305-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jackson E, Bellenger N, Seddon M, Harden S, Peebles C. Ischaemic and non-ischaemic cardiomyopathies-Cardiac MRI appearances with delayed enhancement. Clin Rad 2007; 62: 395-403.","DOI":"10.1016\/j.crad.2006.11.013"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy. Circ Cardiovasc Imaging 2014; 7: 250-8.","DOI":"10.1161\/CIRCIMAGING.113.001144"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Silva MC, Magalh\u00e3es TA, Meira ZMA, <i>et al<\/i>. Myocardial fibrosis progression in duchenne and Becker muscular dystrophy: A randomized clinical trial. JAMA Cardiol 2017; 2: 190-9.","DOI":"10.1001\/jamacardio.2016.4801"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Raman SV, Hor KN, Mazur W, <i>et al<\/i>. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial. Lancet Neurol 2015; 14: 153-61.","DOI":"10.1016\/S1474-4422(14)70318-7"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Epstein AE, DiMarco JP, Ellenbogen KA, <i>et al<\/i>. 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2013; 127: e283-352.","DOI":"10.1161\/CIR.0b013e318276ce9b"},{"key":"28","unstructured":"28. Becker MA, Cornel JH, van de Ven PM, van Rossum AC, Allaart CP, Germans T. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC: Cardiovasc Imaging 2018; 11: 1274-84."}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-354\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:57:58Z","timestamp":1611979078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-354\/_article"}},"subtitle":["A Case for Routine Cardiac Screening?"],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-354","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}